This 2025 review maps cannabis harm reduction strategies across legal, social, and health-related domains, from packaging rules and driving policies to cannabis social clubs and product testing. It is useful as a typology and policy overview, but it does not establish which measures work best because the evidence base is mixed and often qualitative. For readers and clinicians, the value here is in clearer thinking about risk reduction, not in assuming these interventions are already proven.

Read More

Cannabis Use Disorder Treatment Europe Review

CED Clinical Relevanceย ย  #50 Monitored Relevance ย ย Early-stage or contextual signal requiring further evidence before action. ๐Ÿ“‹ Clinical Insightย ย |ย ย CED Clinic Evidence Watch Cannabis Use Disorder Europe Mental Health Audience Patients, caregivers, clinicians, and...

Read More